Galmed says Colospan intraoperative colon tissue assessment study meets feasibility goal in first-in-human trial
GLMD•Usable measurements in every patient
The trial produced usable tissue-quality measurements in every patient, supporting further development toward an intraoperative device for surgical decision-making.
Program expands Colospan beyond CG-100
The program broadens Colospan beyond its CG-100 bypass device, positioning a second platform for future trials and regulatory submissions.
First-in-human proof-of-concept results
Galmed reported successful first-in-human proof-of-concept results for Colospan’s intraoperative colon tissue assessment platform.
Results have been presented in the announcement, with the study meeting its feasibility objective during elective colorectal cancer surgery.
